ResultsIQ

ResultsIQ › Latest results › Nureca Limited

Nureca Limited Q4 FY26 results deck summary

NSE: NURECA · BSE: 543264

Results deck of 29 May 2026, summarised by AI from the filing.

FY26 operating profit ₹8.5 cr vs operating loss ₹7.5 cr in FY25; revenue ₹146.96 cr, PAT ₹2.1 cr.

Key takeaways

  1. FY26 turnaround FY26 operating profit ₹8.5 cr vs operating loss ₹7.5 cr in FY25; revenue ₹146.96 cr, PAT ₹2.1 cr.
  2. Manufacturing Wholly owned subsidiary Nureca Technologies started operations in Apr'22; received 15 CDSCO approvals and USFDA 510K exempt approval for 16 products.
  3. Offline expansion 285 distributors across 29 States & Union Territories, supported by 52-member sales team.

Original filing on BSE

Nureca Limited Q1 FY27 results

As filed: Revenue ₹40.3 cr (+19% year on year), EBITDA ₹3.4 cr, PAT ₹3.1 cr (+207% year on year), EBITDA margin 8.5% (+1,000 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹35.4 cr (+11% year on year), EBITDA −₹5.8 cr (−300% year on year), PAT −₹6.1 cr (−300% year on year), EBITDA margin -16.3% (−1,000 bps). Score 20 of 100, Below trend. Revenue growth was below the company's own trend. EBITDA margin fell 1000 bps year on year. Revenue fell 11% from last quarter. Share price after the results: −14.6% in 27 days (Nifty 500: +2.0%).
  • Q3 FY26: Revenue ₹39.6 cr (+52% year on year), EBITDA ₹3.3 cr, PAT ₹3.7 cr, EBITDA margin 8.2% (+1,000 bps). Score 76 of 100, Above trend. Revenue growth was above the company's own trend. EBITDA margin rose 1000 bps year on year. Other income 47% of PBT. Revenue rose ₹13.6 cr on a year ago, more than the ₹4.0 cr it added the year before. Share price after the results: −8.5% in 30 days (Nifty 500: −0.1%).
  • H1 FY26: Revenue ₹72.0 cr, EBITDA ₹2.0 cr, PAT ₹4.0 cr, EBITDA margin 2.8%. Not scored. No result for the same half-year last year. Share price after the results: +12.3% in 29 days (Nifty 500: +1.2%).
  • Q1 FY26: Revenue ₹34.0 cr (+70% year on year), EBITDA −₹1.0 cr, PAT ₹1.0 cr (−50% year on year), EBITDA margin -2.9% (+706 bps). Score 61 of 100, In line with trend. Revenue growth was well above the company's own trend. EBITDA margin rose 706 bps year on year. Other income 300% of PBT. Tax rate 0%. Consolidated profit -50% but standalone +0%. Profit fell 50% from last quarter. Share price after the results: −18.4% in 30 days (Nifty 500: −3.3%).
  • Q4 FY25: Revenue ₹32.0 cr (+88% year on year), EBITDA ₹2.0 cr, PAT ₹2.0 cr, EBITDA margin 6.3% (+1,000 bps). Score 93 of 100, Above trend. Revenue growth was well above the company's own trend. EBITDA margin rose 1000 bps year on year. Other income 100% of PBT. Tax rate 0%. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: +20.5% in 30 days (Nifty 500: +2.8%).
  • Q3 FY25: Revenue ₹26.0 cr (+18% year on year), EBITDA −₹3.0 cr, PAT −₹3.0 cr, EBITDA margin -11.5% (+664 bps). Score 15 of 100, Below trend. Revenue growth was well above the company's own trend. EBITDA margin rose 664 bps year on year. Revenue fell 16% from last quarter.
  • Q2 FY25: Revenue ₹31.0 cr (0% year on year), EBITDA −₹2.0 cr (−200% year on year), PAT ₹0.0 cr (−100% year on year), EBITDA margin -6.5% (−1,000 bps). Score 9 of 100, Below trend. EBITDA margin fell 1000 bps year on year. Not enough history for a trend yet: scored on growth alone. Profit fell 100% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

Nureca Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.